Pfizer gets FDA panel’s backing in RSV vaccine race
By Khushi Mandowara and Mariam ESunny (Reuters) – A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc’s respiratory syncytial virus (RSV) vaccine, bringing it closer to becoming one of the first approved RSV shots for older adults in the United States. The Food and Drug Administration’s (FDA) advisory committee …
Pfizer gets FDA panel’s backing in RSV vaccine race Read More »